Skip to main content

Circulating miRNAs and interleukin-10 levels in patients with and without chronic abdominal pain.

Wednesday, October 10, 2012 — Poster Session II

Noon – 2:00 p.m

Natcher Conference Center, Building 45




  • W.A. Henderson
  • R.M. Peace
  • N. Fourie
  • A.C. Martino
  • A.Y. Del Valle-Pinero
  • B.L. Majors
  • D. Wang
  • S. Reddy


Chronic abdominal pain (CAP) of unknown origin affects 15-20% of people world-wide. Predictive biomarkers are needed to improve assessment of CAP. Dysregulation of Interleukin-10 (IL-10) is suspected in CAP. This study tested the expression of circulating IL-10 and correlating miRNA in patients with and without CAP. Blood was collected from 21 CAP patients and 33 healthy controls. IL-10 protein levels were measured using immunoassay. RNA was extracted and quantified via spectrophotometry. In a subgroup of twenty gender, age, race matched samples (10 CAP/10 controls) miRNA PCR array was performed followed by digital detection and quantification of 735 miRNAs. IL-10 protein levels were significantly higher in CAP (3.18 ± 0.68 pg/mL) compared to controls (1.35 ± 0.20 pg/mL). Patients with CAP were 2.4 times more likely to have higher IL-10 levels. 340 miRNA were identified via the random variance estimation procedure of which 320 passed filtering criteria. Multiplex targeted profiling revealed eight miRNA that had parametric significance at p ≤.05 and strong correlations with the IL-10 PCR array data. These findings indicate interleukin dysregulation at both the protein and molecular level, and suggest novel diagnostic markers of CAP, and point to potential treatment targets.

back to top